PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
William Lee(Memorial Sloan Kettering Cancer Center), Sewit Teckie(Memorial Sloan Kettering Cancer Center), Thomas Wiesner(Memorial Sloan Kettering Cancer Center), Leili Ran(Memorial Sloan Kettering Cancer Center), Carlos Prieto‐Granada(Memorial Sloan Kettering Cancer Center), Mingyan Lin(Albert Einstein College of Medicine), Sinan Zhu(Memorial Sloan Kettering Cancer Center), Zhen Cao(Memorial Sloan Kettering Cancer Center), Yupu Liang(Memorial Sloan Kettering Cancer Center), Andrea Sboner(Cornell University), William D. Tap(Memorial Sloan Kettering Cancer Center), Jonathan A. Fletcher(Brigham and Women's Hospital), Kety Huberman(Memorial Sloan Kettering Cancer Center), Li-Xuan Qin(Memorial Sloan Kettering Cancer Center), Agnès Viale(Memorial Sloan Kettering Cancer Center), Samuel Singer(Memorial Sloan Kettering Cancer Center), Deyou Zheng(Albert Einstein College of Medicine), Michael F. Berger(Memorial Sloan Kettering Cancer Center), Yu Chen(Memorial Sloan Kettering Cancer Center), Cristina R. Antonescu(Memorial Sloan Kettering Cancer Center), Ping Chi(Memorial Sloan Kettering Cancer Center)
Cited by 631Open Access